Opportunity Radar

← Back to search

Grant forecast

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
G
Agency
Food and Drug Administration
Sub-agency
HHS-FDA
Solicitation #
FOR-FD-25-001
Posted
Aug 14, 2024
CFDA / Assistance listing
93.103
Award floor
$650,000
Award ceiling
$900,000
Contact
Terrin Brown Grantor · terrin.brown@fda.hhs.gov · 2404027610
Source
Grants.gov

Description

The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.

Similar open opportunities